The antibiotic knowledge, attitudes and behaviors of patients, doctors and pharmacists in the WHO Eastern European region - a qualitative, comparative analysis of the culture of antibiotic use in Armenia, Georgia, Kazakhstan, Moldova, Russia and Tajikistan.


Journal

Research in social & administrative pharmacy : RSAP
ISSN: 1934-8150
Titre abrégé: Res Social Adm Pharm
Pays: United States
ID NLM: 101231974

Informations de publication

Date de publication:
02 2020
Historique:
received: 27 09 2018
revised: 07 05 2019
accepted: 19 05 2019
pubmed: 31 5 2019
medline: 9 2 2021
entrez: 31 5 2019
Statut: ppublish

Résumé

To reduce antimicrobial resistance (AMR), initiatives such as surveillance activities and activities to increase knowledge about how and why antibiotics (ABs) are (mis)used are needed. More surveillance systems are in place in the WHO Western European region than in the Eastern region, and only sparse knowledge exists about the current culture of AB use in the Eastern European countries. To investigate AB knowledge, attitudes and behaviors in countries in the WHO Eastern European region in order to identify overall similarities and differences across the region and how AB knowledge, attitudes and behavior patterns may be influenced by the national health care system. Semi-structured interviews were conducted in Armenia, Georgia, Kazakhstan, Moldova, Russia and Tajikistan with patients, doctors and pharmacists. In total, 80 interviews were carried out. A directed content analysis was applied, followed by a comparative analysis, identifying the similarities and differences in AB attitudes, knowledge and behaviors between the countries and discussing how the national health care systems might influence these patterns. Cross-national patterns were identified regarding patients seeking ABs over-the-counter (OTC), patient variations in their requests for ABs when consulting doctors, and, finally, doctors and pharmacists appearing knowledgeable about ABs and their uses, with doctors displaying careful attitudes towards AMR. Indications of national differences between the countries included the ability of patients to afford ABs, prescribing practices of doctors and pharmacist attitudes towards selling ABs without prescriptions. Multiple aspects involved in patient and pharmacist AB decision making were detected, such as various rationales involved in buying/selling ABs OTC, implying that these processes are more complex than previously reported in the literature. Similarities across the Eastern European region could be seen in patient needs and uses of antibiotics obtained OTC at community pharmacies, whereas doctors appeared more influenced by specific structures of the national healthcare system.

Sections du résumé

BACKGROUND
To reduce antimicrobial resistance (AMR), initiatives such as surveillance activities and activities to increase knowledge about how and why antibiotics (ABs) are (mis)used are needed. More surveillance systems are in place in the WHO Western European region than in the Eastern region, and only sparse knowledge exists about the current culture of AB use in the Eastern European countries.
OBJECTIVE
To investigate AB knowledge, attitudes and behaviors in countries in the WHO Eastern European region in order to identify overall similarities and differences across the region and how AB knowledge, attitudes and behavior patterns may be influenced by the national health care system.
METHODS
Semi-structured interviews were conducted in Armenia, Georgia, Kazakhstan, Moldova, Russia and Tajikistan with patients, doctors and pharmacists. In total, 80 interviews were carried out. A directed content analysis was applied, followed by a comparative analysis, identifying the similarities and differences in AB attitudes, knowledge and behaviors between the countries and discussing how the national health care systems might influence these patterns.
RESULTS
Cross-national patterns were identified regarding patients seeking ABs over-the-counter (OTC), patient variations in their requests for ABs when consulting doctors, and, finally, doctors and pharmacists appearing knowledgeable about ABs and their uses, with doctors displaying careful attitudes towards AMR. Indications of national differences between the countries included the ability of patients to afford ABs, prescribing practices of doctors and pharmacist attitudes towards selling ABs without prescriptions. Multiple aspects involved in patient and pharmacist AB decision making were detected, such as various rationales involved in buying/selling ABs OTC, implying that these processes are more complex than previously reported in the literature.
CONCLUSIONS
Similarities across the Eastern European region could be seen in patient needs and uses of antibiotics obtained OTC at community pharmacies, whereas doctors appeared more influenced by specific structures of the national healthcare system.

Identifiants

pubmed: 31142446
pii: S1551-7411(18)30841-6
doi: 10.1016/j.sapharm.2019.05.014
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Comparative Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

238-248

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Susanne Kaae (S)

Social and Clinical Pharmacy Group, Department of Pharmacy, Faculty of Health and Medical Sciences, Universitetsparken 2, 2100, Kbh. Ø, Denmark. Electronic address: susanne.kaae@sund.ku.dk.

Lilit Ghazaryan (L)

The Scientific Centre of Drug and Medical Technology Expertise Under the Ministry of Health, 49/4 Komitas ave, Yerevan, 0051, Armenia. Electronic address: lili@pharm.am.

Karaman Pagava (K)

Department of Pediatrics, Tbilisi State Medical University, Tbilisi, Georgia. Electronic address: kpagava@yahoo.com.

Irma Korinteli (I)

Department of Pediatrics, Tbilisi State Medical University, Tbilisi, Georgia. Electronic address: korinteli7@yahoo.com.

Larissa Makalkina (L)

JSC "Astana Medical University", Astana, Kazakhstan. Electronic address: larisa_makalkina@mail.ru.

Gaukhar Zhetimkarinova (G)

Department of Clinical Pharmacy, National Research Center for Maternal and Child Health, Astana, Kazakhstan. Electronic address: gohachkalove@mail.ru.

Ainur Ikhambayeva (A)

JSC "Astana Medical University", Astana, Kazakhstan. Electronic address: ainur_ihambaeva@mail.ru.

Elizaveta Tentiuc (E)

Pharmacovigilance Department, Medicines and Medical Devices Agency, 2/1 Korolenko str, Chisinau, 2028, Republic of Moldova. Electronic address: elizaveta.tentiuc@amed.md.

Svetlana Ratchina (S)

Internal Medicine with Cardiology and Functional Diagnostics Course named after V.S. Moiseev, Russian Friendship University, Moscow, Russia. Electronic address: svetlana.ratchina@antibiotic.ru.

Polina Zakharenkova (P)

Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy, Smolensk, Russia. Electronic address: polina.antoschkina@yandex.ru.

Salomudin Yusufi (S)

Department of Science, Avicenna Tajik State Medical University, Dushanbe, Tajikistan. Electronic address: salomudin@mail.ru.

Nargis Maqsudova (N)

Department of Health Systems, WHO CO, Dushanbe, Tajikistan. Electronic address: nargis.maqsudova@gmail.com.

Louise Druedahl (L)

Social and Clinical Pharmacy Group, Department of Pharmacy, Faculty of Health and Medical Sciences, Universitetsparken 2, 2100, Kbh. Ø, Denmark. Electronic address: louise.druedahl@sund.ku.dk.

Sofia Kälvemark Sporrong (SK)

Social and Clinical Pharmacy Group, Department of Pharmacy, Faculty of Health and Medical Sciences, Universitetsparken 2, 2100, Kbh. Ø, Denmark. Electronic address: sofia.sporrong@sund.ku.dk.

Lourdes Arevalo Cantarero (LA)

Social and Clinical Pharmacy Group, Department of Pharmacy, Faculty of Health and Medical Sciences, Universitetsparken 2, 2100, Kbh. Ø, Denmark. Electronic address: lou.cantarero@sund.ku.dk.

Lotte Stig Nørgaard (LS)

Social and Clinical Pharmacy Group, Department of Pharmacy, Faculty of Health and Medical Sciences, Universitetsparken 2, 2100, Kbh. Ø, Denmark. Electronic address: lotte.norgaard@sund.ku.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH